Therefore, we assumed that the use of ACE inhibitors for controlling high blood pressure in patients with clear cell renal cell carcinoma will increase their ACE2 expression levels, which may help to improve survival rates if the administration of the ACE inhibitor is prioritized when choosing a high blood pressure control drug for these patients. The gene discussed is ACE; the disease is clear cell renal carcinoma.